# Mid Atlantic Bio Angels

> Mid Atlantic Bio Angels is a VC fund backing Biotechnology and Health Care. See 26 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 26
- Last investment: Jan 2026
- Lead investor: 31%
- Last fund: Jan 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company-beta/3031490
- X (Twitter): http://twitter.com/BioAngelsGroup
- Website: http://bioangels.net

Mid Atlantic Bio Angels is a VC fund in New York focused on Biotechnology and Health Care. Mid Atlantic Bio Angels group (MABA), is an angel investor group focused exclusively on new and emerging life science companies. Membership in MABA is by invitation only, and is extended to active, accredited investors (life science angels) who wish to make investments in life science companies, as well as institutional investors and life sciencecompany venture arms wishing to invest alongside the angels.MABA places no geographical restrictions or requirements for presenting companies, as long as meaningful and effective post-investment monitoring of these companies can be achieved.

## Contacts

5 contacts available for Mid Atlantic Bio Angels. Shizune tracks 5 team members at Mid Atlantic Bio Angels. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/mid-atlantic-bio-angels?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 13 | 50% |
| Health Care | 10 | 38% |
| Medical Device | 8 | 31% |
| Medical | 5 | 19% |
| Therapeutics | 4 | 15% |

21 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 7 | 27% |
| Series A | 5 | 19% |
| Seed | 4 | 15% |
| Angel | 4 | 15% |
| Series B | 3 | 12% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 15 | 58% |
| France | 1 | 4% |
| Israel | 1 | 4% |
| United Kingdom | 1 | 4% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Eric D. Kanter | Member--Steering Committee | 0 | https://shizune.co/investors/profile/eric-d-kanter |
| John Oates | Member | 0 | https://shizune.co/investors/profile/john-oates-a1d3 |
| Kenny Nova | Member / Investor | 0 | https://shizune.co/investors/profile/kenny-nova |
| Stephen Goodman | Co-Founder | 0 | https://shizune.co/investors/profile/stephen-goodman |
| Yaniv Sneor | Founder | 5 | https://shizune.co/investors/profile/yaniv-sneor |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BMI OrganBank | BMI OrganBank develops innovative medical devices and perfusion technology to enhance organ and tissue preservation for transplantation. The company collaborates with academic institutions to expand the possibilities of organ transplantation and improve patient outcomes. BMI OrganBank focuses on creating solutions that could transform kidneytransplantation and other organ preservation methods, benefiting thousands of patients in need of transplants. |  | Venture - Series Unknown | Jan 12, 2026 |  |
| Astrocyte Pharmaceuticals | Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease. | $6M | Series B | Aug 18, 2023 |  |
| Hilltop BioSciences | Hilltop Bio provides regenerative therapies that help injured horses regenerate damaged tissues and assist in restoring them. It utilizes its backgrounds in veterinary therapies to find better ways to help horses heal. It is driven by its mission of producing regenerative therapies that science has proven to be safe, effective, and rapid.Thecompany was founded in 2018 and is headquartered in Mansfield, Massachusetts. |  | Angel | Mar 30, 2023 |  |
| Hilltop BioSciences | Hilltop Bio provides regenerative therapies that help injured horses regenerate damaged tissues and assist in restoring them. It utilizes its backgrounds in veterinary therapies to find better ways to help horses heal. It is driven by its mission of producing regenerative therapies that science has proven to be safe, effective, and rapid.Thecompany was founded in 2018 and is headquartered in Mansfield, Massachusetts. |  | Seed | Mar 30, 2023 |  |
| The Shape Sensing Company | The Shape Sensing Company provides 3D shape-sensing solutions for the medical, aerospace, and energy sectors. |  | Angel | Nov 10, 2022 |  |
| FEMSelect | FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, anddeployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization.FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel. | $9M | Series B | Oct 19, 2022 |  |
| DeepLife | DeepLife uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.DeepLife is a biotech company with a mission to build the next generation of system biology. The company works in a highly collaborative translational manner, to facilitate the transition of discoveries from the laboratory to patients. Thecompany operates through collaboration with academic groups in their respective areas of expertise. | $5.9M | Series A | Oct 18, 2022 |  |
| New View Surgical | New View Surgical is an emerging medical device company focused on the development and commercialization of the VisionPort™ System, a novel surgical imaging and access system for minimally invasive surgery. The company is led by an experienced team of medical device innovators and commercial experts who have come together to design andcommercialize impactful solutions that meet a variety of unmet market needs. The company’s proprietary VisionPort™ system combines multiple imaging and access devices into just one simple, easy-to-use device that is disposable and is expected to bring a variety of clinical and economic advantages to minimally invasive surgery operating rooms around the world. | $9M | Series B | Nov 02, 2021 |  |
| Seneca Therapeutics | Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate.Seneca Therapeutics isheadquartered in Blue Bell, Pennsylvania. | $5M | Venture - Series Unknown | May 04, 2021 |  |
| Astrocyte Pharmaceuticals | Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease. | $6M | Series A | May 03, 2021 |  |

10 of 26 investments shown.

## Co-investors
- [New York Angels](https://shizune.co/investors/profile/new-york-angels) — VC Fund, 6 deals together
- [Keiretsu Forum](https://shizune.co/investors/profile/keiretsu-forum) — VC Fund, 5 deals together
- [Keiretsu Capital](https://shizune.co/investors/profile/keiretsu-capital) — VC Fund, 4 deals together
- [Life Science Angels](https://shizune.co/investors/profile/life-science-angels) — VC Fund, 3 deals together
- [AJI Capital](https://shizune.co/investors/profile/aji-capital) — VC Fund, 2 deals together
- [Ariel Southeast Angel Partners](https://shizune.co/investors/profile/ariel-southeast-angel-partners) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Medical Device VC Funds in Middle East](https://shizune.co/investors/medical-device-vc-funds-middle-east)
- [Medical Device VC Funds in Israel](https://shizune.co/investors/medical-device-vc-funds-israel)
- [Medical Device Investors in Middle East](https://shizune.co/investors/medical-device-investors-middle-east)
- [Medical Device Investors in Israel](https://shizune.co/investors/medical-device-investors-israel)

## FAQ

### What does Mid Atlantic Bio Angels invest in?

Mid Atlantic Bio Angels invests primarily in Biotechnology, Health Care and Medical Device startups, most often at Funding Round and Series A stage. Most of the 26 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Mid Atlantic Bio Angels?

Public channels for Mid Atlantic Bio Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Mid Atlantic Bio Angels?

The team at Mid Atlantic Bio Angels includes Eric D. Kanter (Member--Steering Committee), John Oates (Member) and Kenny Nova (Member / Investor). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co